Dmg Group, LLC Eli Lilly & CO Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dmg Group, LLC holds 1,074 shares of LLY stock, worth $801,418. This represents 0.79% of its overall portfolio holdings.

Number of Shares

1,074

Previous 1,217 11.75%

Holding current value

$801,418

Previous $1.1 Million 13.62%

% of portfolio

0.79%

Previous 0.95%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$772.14 - $960.02 $110,416 - $137,282	-143 Reduced 11.75%	1,074 $951,000
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $216,011 - $270,893	-298 Reduced 19.67%	1,217 $1.1 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $2,961 - $3,961	-5 Reduced 0.33%	1,515 $1.18 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $131,297 - $154,782	-250 Reduced 14.12%	1,520 $886,000
Q3 2023 Oct 26, 2023	SELL	$434.7 - $599.3 $119,977 - $165,406	-276 Reduced 13.49%	1,770 $950,000
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $35,424 - $47,366	-101 Reduced 4.7%	2,046 $959,000
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $18,637 - $21,889	-60 Reduced 2.72%	2,147 $753,000
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $25,724 - $29,973	-80 Reduced 3.5%	2,207 $806,000
Q3 2022 Oct 27, 2022	SELL	$296.48 - $337.87 $77,381 - $88,184	-261 Reduced 10.24%	2,287 $735,000
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $83,061 - $97,526	298 Added 13.24%	2,548 $827,000
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $146,446 - $181,995	-624 Reduced 21.71%	2,250 $627,000
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $646,218 - $801,960	2,874 New	2,874 $680,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account